Setting The Stage For Success: The Irish Bioindustry Association - - BioPharm International

ADVERTISEMENT

Setting The Stage For Success: The Irish Bioindustry Association

BioPharm International


BioMed Ireland. IBIA participated in BioMed Ireland, the first North-South network for the health technology and biotechnology industries. This joint initiative with the Irish Medical Devices Association (IMDA), the Irish BioIndustry Association, BioBusinessNI, and InterTradeIreland, capitalizes on recent rapid growth in these sectors by developing cross-border business networks. These networks create an all-island critical mass for innovation, growth, and overall global competitiveness and provide a forum to:

  • Consolidate and maximize mutual learning, knowledge transfer, and networking activities
  • Identify and roll out models of best practice
  • Provide strategic benchmarking, both internally and externally for the island
  • Provide the first all-island economic impact study for the sector
  • Provide an all-island focal point for the sector and facilitate the global promotion of health technology and biotechnology companies based in Ireland

Conclusion

The Irish BioIndustry Association (IBIA) is the leading representative body for the biotechnology industry in Ireland. IBIA's role is to promote, support, and encourage further development of the multinational and indigenous biotech sector in Ireland.

To achieve these aims, the association engages in a range of activities to protect intellectual property and patents, encourage a positive regulatory environment, and promote research and development collaborations. In these activities, IBIA works closely with research institutions and organizations such as Enterprise Ireland's Biotechnology Directorate, Industrial Development Agency, and Science Foundation Ireland,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here